Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) SHZ

9.76

-0.02(-0.20%)

Updated at June 03 01:27PM

Currency In CNY

Valuation

Market Cap17.3B
Enterprise Value18.06B
P/E Ratio37.73
PEG Ratio-0.89
Price/Sales Ratio2.25
Price/Book Ratio1.18
Enterprise/Revenue2.44
Enterprise/EBITDA13.06

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.07
Operating Margin0.12

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue5.48B
Revenue/Share3.69
Gross Profit1.74B
EBITDA846.59M
Net Income349.49M
Diluted EPS0.24

Balance Sheet

Total Cash3.5B
Total Cash/Share2.39
Total Debt2.79B
Total Debt/Equity0.23
Current Ratio2.15
Book Value Per Share8.33

Price History

52-Week Change-21.07
52-Week High14.34
52-Week Low9.62
Moving Average 50 Days10.8
Moving Average 200 Days11.77

Statistics

Average Volume4.35M
Shares Outstanding1.25B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.56
Payout Ratio0.12
Last Split Factor8:5
Last Split DateJune 13, 2016